Supermax Corporation

SUPERMX

MYL7106OO007

Medical Equipment, Supplies & Distribution

End-of-day quote BURSA MALAYSIA Other stock markets 06:00:00 2024-05-30 pm EDT			5-day change	1st Jan Change
0.885 ^MYR	-0.56%		-5.85%	-5.85%

May. 29	Supermax Trims Loss in Fiscal Q3	MT
May. 28	Supermax Corporation Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	CI

Supermax Corporation Berhad Announces Resignation of Dr. Yap Lang Ling as Independent and Non Executive Director

May 08, 2024 at 02:32 am EDT

Supermax Corporation Berhad announced the resignation of Dr. Yap Lang Ling as Independent and Non Executive Director. Date of change is May 8, 2024. Age is 51.

Reason: Due to personal reasons.

Latest news about Supermax Corporation

Supermax Trims Loss in Fiscal Q3	May. 29	MT
Supermax Corporation Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	May. 28	CI
Supermax Buys Back 1 Million Shares	May. 28	MT
Supermax Buys Out Supermax Healthcare Canada for C$5.5 Million	May. 10	MT
Supermax Corporation Berhad entered into a Share Sale Agreement to acquire remaining 33% stake in Supermax Healthcare Canada Inc. from Sylvain Bergeron for CAD 5.5 million.	May. 08	CI
Supermax Corporation Berhad Announces Resignation of Yap Lang Ling as Independent and Non Executive Chairman of Risk Committee	May. 08	CI
Supermax Corporation Berhad Announces Resignation of Dr. Yap Lang Ling as Independent and Non Executive Director	May. 08	CI
Supermax Buys Back Shares	May. 03	MT
Supermax Corporation Berhad Announces Audit Committee Changes, Effective May 8, 2024	May. 02	CI
Supermax Corporation Berhad Announces Re-Designation of Wong Phait Lee from Non Executive Director to Executive Director, Effective May 8, 2024	May. 02	CI
Supermax Buys Back Shares	May. 02	MT
Supermax Buys Back Shares	Apr. 30	MT
Supermax Corporation Berhad commences an Equity Buyback Plan, under the authorization approved on December 8, 2023.	Apr. 23	CI
Supermax Corporation Berhad Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	Feb. 20	CI
Supermax Names CEO, COO	Dec. 20	MT
Supermax Corporation Berhad Appoints Yip Kit Weng as Independent and Non Executive Member of Risk Committee, Effective January 2, 2024	Dec. 19	CI
Supermax Corporation Berhad Appoints Yap Lang Ling as Independent and Non Executive Chairman of Risk Committee, Effective January 2, 2024	Dec. 19	CI
Supermax Corporation Berhad Announces Resignation of Albert Saychuan Cheok, as Independent and Non Executive Member of Risk Committee, Effective 02 Jan 2024	Dec. 19	CI
Supermax Corporation Berhad Appoints Yip Kit Weng as Independent and Non Executive Director, Effective January 2, 2024	Dec. 18	CI
Supermax Corporation Berhad Announces Resignation of Albert Saychuan Cheok as Independent and Non Executive Member of Risk Committee, Effective January 2, 2024	Dec. 18	CI
Supermax Corporation Berhad Appoints Yap Lang Ling as Independent and Non Executive Chairman of Risk Committee, Effective January 2, 2024	Dec. 18	CI
Supermax Corporation Berhad Announces Re-Designation of Tan Chee Keong as Senior Executive Director from Executive Director. Effective January 2, 2024	Dec. 18	CI
Supermax Corporation Berhad Appoints Gan Kim Khoon as Independent and Non Executive Director, Effective January 2, 2024	Dec. 18	CI
Supermax Corporation Berhad Appoints Wong Phait Lee as Independent and Non Executive Director, Effective January 2, 2024	Dec. 18	CI
Supermax Corporation Berhad Appoints Yap Lang Ling as Independent and Non Executive Director, Effective January 2, 2024	Dec. 18	CI

Supermax Corporation Berhad is an investment holding company, engaged in the production of rubber gloves. The Company operates through four segments: Investment holding, Manufacturing of gloves, Trading of gloves and Others. The Company is an international manufacturer, distributor, and marketer of medical gloves. It manufactures various types of nitrile latex and natural rubber gloves, which are exported to over 165 countries around the world, such as the United States of America, European Union, Middle East, Asia, and South Pacific countries. The Company owns a range of brands, such as Supermax, Aurelia and Maxter, which are used by laboratories, hospitals, pharmacists, doctors, and surgeons throughout the world. It produces over 26 billion pieces of gloves per year. It has approximately eight distribution centres based in the United States of America, Brazil, Canada, Germany, Hong Kong, and United Kingdom.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-28 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Supermax Corporation

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

0.885 MYR

Average target price

0.9583 MYR

Spread / Average Target

+8.29%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Medical Supplies

	1st Jan change	Capi.
SUPERMAX CORPORATION	-5.85%	482M
COLOPLAST A/S	+6.84%	26.97B
SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED	-40.08%	2.67B
WINNER MEDICAL CO., LTD.	-19.95%	2.4B
HARTALEGA HOLDINGS	+16.30%	2.28B
INTCO MEDICAL TECHNOLOGY CO., LTD.	+7.28%	2.24B
TOP GLOVE CORPORATION BHD.	+16.67%	1.79B
HARBIN FUERJIA TECHNOLOGY CO., LTD.	-13.56%	1.82B
GVS S.P.A.	+18.92%	1.26B
KOSSAN RUBBER INDUSTRIES	+20.00%	1.2B

Medical Supplies